Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Sunscreen compliance with regional clinical practice guidelines and product labeling standards in New Zealand.

Sporer ME, Mathy JE, Kenealy J, Mathy JA.

J Prim Health Care. 2016 Mar;8(1):30-4. doi: 10.1071/HC15019.

PMID:
27477372
2.

Mechanism of resistance of hepatitis C virus replicons to structurally distinct cyclophilin inhibitors.

Puyang X, Poulin DL, Mathy JE, Anderson LJ, Ma S, Fang Z, Zhu S, Lin K, Fujimoto R, Compton T, Wiedmann B.

Antimicrob Agents Chemother. 2010 May;54(5):1981-7. doi: 10.1128/AAC.01236-09. Epub 2010 Feb 22.

3.

Class III phosphatidylinositol 4-kinase alpha and beta are novel host factor regulators of hepatitis C virus replication.

Borawski J, Troke P, Puyang X, Gibaja V, Zhao S, Mickanin C, Leighton-Davies J, Wilson CJ, Myer V, Cornellataracido I, Baryza J, Tallarico J, Joberty G, Bantscheff M, Schirle M, Bouwmeester T, Mathy JE, Lin K, Compton T, Labow M, Wiedmann B, Gaither LA.

J Virol. 2009 Oct;83(19):10058-74. doi: 10.1128/JVI.02418-08. Epub 2009 Jul 15.

4.

Combinations of cyclophilin inhibitor NIM811 with hepatitis C Virus NS3-4A Protease or NS5B polymerase inhibitors enhance antiviral activity and suppress the emergence of resistance.

Mathy JE, Ma S, Compton T, Lin K.

Antimicrob Agents Chemother. 2008 Sep;52(9):3267-75. doi: 10.1128/AAC.00498-08. Epub 2008 Jun 30.

Supplemental Content

Loading ...
Support Center